Level of 25(OH)D Serum, Expression of Interleukin 4 and Glucocorticoid Receptor of Mononuclear Cell in Steroid Resistance Nephrotic Syndrome Children by Deckert, V. M. (Vonny) et al.
THE JOURNAL OF TROPICAL LIFE SCIENCE                                                      OPEN     ACCESS Freely available online
VOL. 5, NO. 3, pp. 141-146, September, 2015                                                                       
Level of 25(Oh)D Serum, Expression of Interleukin 4 and Glucocorticoid Receptor of 
Mononuclear Cell in Steroid Resistance Nephrotic Syndrome Children 
Vonny Mariany Deckert1, Krisni Subandiyah2*, Loeki Enggar Fitri3
1Magister Program in Biomedical Sciences, Faculty of Medicine, University of Brawijaya Malang
2Department of Pediatric, Saiful Anwar General Hospital, Malang
3Department of Parasitology, Faculty of Medicine, University of Brawijaya Malang
ABSTRACT
Nephrotic syndrome (NS) is an autoimmune disease and its steroid resistance status supposed correlate
with 25(OH)D level and IL-4 expression. The aimed of this study was investigated 25(OH)D plasma level, IL-4
and GR expression of PBMC in steroid sensitive and resistant pediatric NS patients and the association of those
parameters. 27 subjects were divided into three groups (control group, steroid resistant NS group, and steroid-sen-
sitive NS group). Peripheral blood mononuclear cells (PBMCs) isolated using the Ficoll-Hypaque method. Plasma
25(OH)D level was measured using ELISA method. IL-4 and GR expression were measured using flow cytometry
of PBMCs. This study showed that 25(OH)D level and GR expression were significantly different in the control
group compared to steroid resistant NS group (p<0.05). Plasma 25(OH)D level, IL-4, and GR expression were not
correlated each other in NS patients (p>0.05). Plasma 25(OH)D level, IL-4 and GR expression were not contrib-
uted to steroid resistance in NS patients. However, GR expression has the highest contribution to steroid resis-
tance of NS patient (Wald score 1.198). Plasma 25(OH)D level and GR expression were lower in steroid resistant
NS group. GR expression has the highest contribution in steroid resistance of NS patients. 
Keywords: 25(OH)D level, GR expression, IL-4 expression
Nephrotic syndrome (NS) defined as a glomerular
disease that characterized by proteinuria, edema, and
hypoalbuminemia. This disease could affect all ages, es-
pecially 2-6 years old child with male: female ratio [1].
Nephrotic syndrome occurred 2-7 new case per 100.000
children  [2].  Previous  data  had  been  reported  that
there was 101 case (34%) idiopathic NS from total 297
nephrology disease at  Pediatric  Department  of Saiful
Anwar Hospital [3].
Idiopathic NS is an autoimmune mediated disease
that  both  steroid  sensitive  and  steroid  resistant  pos-
sessed T cell dysfunction, decreased of 25(OH)D level,
and  glucocorticoid  receptor  (GR)  expression.
Nephrotic syndrome caused by an imbalance of Th1
and Th2 cytokines that could trigger podocyte dysfunc-
tion and massive proteinuria [4]. IL-4 and IL-13 could
induce proteinuria in idiopathic NS patient [5]. 
A previous study showed that glucocorticoid recep-
tor (GR) expression increase in the remission stage of
NS and decreased GR expression in steroid resistant
NS compared with steroid sensitive NS [6]. Further-
more,  GR  expression  negatively  correlated  with
histopathological damage of glomerulus [7]. 
25(OH)D level in NS patients also decrease caused
by  renal  function  impairment.  Takeda  has  been  de-
scribed that an active form of vitamin D3 could modu-
late the immune response [8]. Vitamin D3 could re-
verse GR downregulation induced by ligand through
its interaction with GC signaling pathway [8]. The role
of vitamin D3 in immune response had been studied in
steroid  resistant  asthmatic  patients.  A  study  showed
that administration active form of vitamin D3 could in-
crease IL-4, IL-5, IL-13 expression by Th2 and IL-10
and TGF by Treg [9].
Previous study showed enhancement of various cy-
tokines production such as IL-1 IL-2, IL-4 and TNF-α,
and  also  decreased  of  IL-10  production  in  minimal
changes  NS  patient’s  peripheral  blood  mononuclear
cells (PBMC) [10]. 
Its immunomodulatory effects of vitamin D could
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suppress  Th1:  IFN-Ɣ;  IL-2;  Th17:  IL-17  IL-1;  IL-6;
TNF-α; IL-12; IL-23 secretion, suppression of Treg: IL-
10; TGF-β and also enhancement of Th2: IL-4; IL-5;
IL-13 secretion [11]. In other hands IL-4 and IL-2 de-
crease  GRα without  affect  GRβ,  which  further  con-
cluded that steroid resistance induced by IL-4 and IL-2
and marked by decreased expression of GRα [12].
This study was conducted to investigate 25(OH)D
plasma  level,  IL-4  and  GR  expression  of  PBMC in
steroid sensitive and resistant pediatric NS patients and
their association.
Study Design 
This study was cross-sectionally designed to mea-
sure vitamin D (25(OH)D) plasma level, GR and IL-4
expression of PBMC in steroid sensitive NS, steroid re-
sistant  NS,  and  control  group.  This  study  was  con-
ducted in nephrology policlinic and ward of Pediatric
Department, Dr. Saiful  Anwar Hospital Malang, and
Biomedical Laboratory, Faculty of Medicine, Brawijaya
University Malang. This study had been approved by
Ethical  Committee  of  Medical  Faculty  of  Medicine,
Brawijaya University.
Population and Subject
Research  subject  included in  this  study was  nine
subjects in each group. Inclusion criteria of topics are
classified as steroid sensitive and steroid resistant NS
aged 1-14 years old and allowed by his/her parents to
join in this study (informed consent). Exclusion criteria
of  subjects  is  NS  which  classified  as  secondary  NS
(caused by extra-renal factor such as chemical/drugs,
systemic disease such as SLE or Henoch Schonlein, in-
fectious  disease  such  as  malaria,  hepatitis),
congenital/infantile NS, patient with autoimmune dis-
ease (SLE, DM), patient with allergy (asthma, rhinitis,
atopic dermatitis), patients with severe infection, liver
dysfunction, and patient with vitamin D supplementa-
tion. 
PBMC Isolation
Blood sample in Vacutainer EDTA/heparin mixed
properly, and then mixed with PBS (1:1). Blood sam-
ple-PBS take using micropipette and then overlaid to
falcon  tube  which  already  contains  Ficoll-Hipaque
d=1.077 g/mL through its wall (volume sample: Ficoll-
Hipaque 1:1). This mixture then centrifuged at room
temperature 1000 rpm for 30 min. After centrifuged,
this mixture will form 4 layer (plasma, PBMC, Ficoll-
Hipaque, and granulocyte or erythrocyte). PBMC ring
has taken slowly using micropipette and then placed in
new 15 mL centrifuge bottle. PBMC solution and then
washed  with  PBS  10  mL  and  centrifuged  at  room
temperature, 1200 rpm for 10 min. Pellet washed again
with PBS and then centrifuged at room temperature,
1200  rpm for  10  min  (this  process  is  repeated  two
times). PBMC formed as a pellet in the bottom of the
bottle. 
Measurement of GR Expression in CD3
PBMC’s pellet was added with PE-conjugated anti-
human  CD357  (GITR)  antibody  (catalog  number
311604)  and then incubated for 15 min in the dark
room.  After  that,  the  pellet  was  centrifuged at  2500
rpm for 3 min. Then, the pellet was added to one mL
fixation  buffer  solution  in  each  tube,  centrifuged  at
2500  rpm,  4°C for  3  min.  The  supernatant  was  re-
moved.  Cell  pellet  that  has  been fixated  then resus-
pended  by  added  1x  permeabilization  washed  buffer
and centrifuged at 2500 rpm, 4°C for 3 min. After this
process, the cell pellet was resuspended in added 0,5 ml
cell staining buffer and then analyzed using flow cy-
tometry. Expression of GR analyzed using software BD
Cell Quest Pro. 
Measurement of IL-4 Expression 
PBMC’s pellet was added with PerCP/Cy5.5 anti-
human IL-4 (catalog number MP 4-25D2) and then in-
cubated in the dark room for 15 min. After that, the
pellet was added to 1 mL cell staining buffer and then
centrifuged for 3 min at Mystral-1000 rt and hatch cen-
trifuge at 2500 rpm, room temperature continuously.
Supernatant was removed, then added with 1 ml fixa-
tion buffer, incubated for 15 min in dark room, room
temperature, and centrifuged for 3 min in Mystral-1000
rt and hettch centrifuge at 2500 rpm at room tempera-
ture continuously. 
The supernatant was removed, the pellet was added
with permeable wash buffer and then incubated for 15
min in a dark room at room temperature. After this
process, centrifuged again for 3 min in Mystral-1000 rt
and hatch centrifuge at 2500 rpm at room temperature
continuously. The supernatant was removed, and the
pellet was added with cell staining buffer 500 µl, and
then placed in a sample tube for flow cytometry ma-
chine, BD Facs Calibur. IL-4 expression analyzed using
software BD Cell Quest pro.
Measurement of Plasma 25(OH)D Level
Three  polypropylene  tube  that  used  for  control,
sample, and calibrator were prepared. 1 ml 25-D biotin
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solution was added to all tube, and then vortex for 10
seconds. Each of calibrator dilution added 200 µl, con-
trol or sample in each appropriate well according to an
antibody-coated  plate/microplate.  The  plate  was  cov-
ered  with  plastic  and then incubated  in  18-250C for
two  hours.  All  well  then  washed  three  times  using
wash solution.  200 µl  conjugate  were added to each
well  using  multichannel  pipette.  Plate  covered  again
with  plastic,  incubated  in  18-250C for  30  min  (this
process  repeat  2  times).  200  µl  TMB  substrate  was
added into each well, and then covered with plastic, in-
cubated in 18-250C for 30 minutes. 100 µl stop solution
was added to each well. Absorbance was measured in
each well at 450 nm using microplate reader in 30 min
after added stop solution. 
Characteristics of Subjects
This study involved 27 subjects divided into three
groups: control group, steroid resistant NS group, and
steroid-sensitive  NS group.  The subject  characteristic
such as sex, age, nutrition status described in Table 1.
Level of Plasma 25(OH)D
Figure 1 showed 25(OH)D level was 23.86 ng/mL
for the control group, 15.50 ng/mL for steroid sensitive
NS group,  and 10.88 ng/mL for steroid-resistant  NS
group.  One  way  ANOVA showed  significant  differ-
ences  between groups (p<0.05).  Post Hoc Tukey test
showed  significant  differences  between  the  control
group and steroid resistant group (p = 0.003). 
IL-4 Expression
Figure 2 showed IL-4 expression was 2.89% for the
control  group,  0.86% for  steroid-resistant  NS group,
and 1.09% for steroid-sensitive NS group. Non-para-
metric test Kruskal-Wallis showed no significant differ-
ences among groups (p = 0.095). 
GR Expression
     Figure 3 showed GR expression was 3.86% for the
control  group,  1.74% for  steroid-resistant  NS group,
and  2.66% for  steroid-sensitive  NS group.  One  way
ANOVA  showed  significant  differences  between
groups (p<0.05). Post Hoc Tukey test showed signifi-
cant differences between the control group and steroid-
resistant group (p = 0.008).
Correlation of Plasma 25(OH)D Level,  IL-4 and GR
Expression
Pearson correlation test showed no significant cor-
relation between 25(OH)D level  and IL-4 expression
(p>0.05, r = 0.382), 25(OH)D level and GR expression
(p>0.05, r = 0.417), IL-4 expression and GR expression
(p>0.05,  r  =  0.271).  Logistic  regression  test  showed
25(OH)D level,  IL-4  expression,  and  GR expression
has  no significant contribution for steroid resistance.
However,  from  3  parameters,  GR  expression  has
highest Wald score (1.198) which mean GR expression
is the most significant predictor for steroid resistance
in NS patients. 
Characteristics of Subjects
    Data showed a range of patient age was 5-10 years
old for steroid sensitive NS, 10-14 years old for steroid-
resistant NS. This result consistent with the previous
study reported that 75% NS aged less than 10 (ten)
years old [2].
This study showed in NS groups dominated by the
female. Epidemiological data showed in children aged
younger than 8 (eight) years old at the onset of disease,
male: female ratio varied from 2:1 until 3:2. However,
in  older  children,  male:  female  ratio  almost  same.
Other data indicated that  66% patients  with MCNS
(minimal changes nephrotic syndrome) or FSGS (focal
segmental glomerulosclerosis) was male, but 65% pa-
tients with MPGN was female [16]. Berg and Wening
[10] speculated that a higher prevalence of NS in the
male might be correlated with abnormal T cell clone
that frequently occurred in thymus gland [10]. 
Nutritional  status showed in all  three groups has
good  nutrition  status.  NS  patients  possessed  higher
risk factor for developmental impairment caused by NS
itself or its complication [13]. 
Plasma 25(OH)D Level, IL-4 and GR Expression 
Data  showed  that  plasma  25(OH)D level  in  the
control  group  significantly  higher  than  NS  groups.
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Furthermore,  a  post  hoc  test  showed  that  plasma
25(OH)D level significantly different between a control
group and  steroid-resistant  group,  but  no  significant
differences between steroid-resistant and steroid-sensi-
tive groups. This results indicated that vitamin D has a
role in the development of NS. However, because of
limitation of study design (observational),  we cannot
conclude whether vitamin D caused NS or NS caused
vitamin D dysfunction. This result also indicated that
vitamin D might be a role for steroid resistance in NS
patient.
Cheng  et  al.  [14]  reported  that  dexamethasone
combined with vitamin D3 protect podocyte from ex-
perimental  injury.  Colin  et  al.  [15]  showed  that
1,25(OH)2D3  could  inhibit  tumor  necrosis  factor
(TNF),  interleukin-17  (IL-17)  and  interferons  (IFN)
production, and also triggered IL-4, IL -5, and IL-10
expression in PBMC or CD4T-cell. 
Calcitriol administration in T cell culture could in-
hibit  proinflammatory  cytokine  production  in  Th1,
Th9, and Th22 and enhance production of anti-inflam-
matory cytokines in Th2. Clinically, 1,25(OH)2D3 has
the beneficial effect of reducing proteinuria and altered
renin-angiotensin-aldosterone  (RAAS)  system.
Histopathologically,  1,25(OH)2D3 could preserve  the
structural  and  functional  integrity  of  podocytes  and
also  suppress  renin  expression  directly  in  transcrip-
tional stage [16].
This study also showed that IL-4 expression lower
in the control group compared with NS group and sig-
nificantly  different  with  steroid  resistant  NS  group.
This data indicated that NS group showed activation of
Th2-cells. Kanai described that in NS occurred imbal-
ance of Th1 and Th2 ratio whereas Th2 more domi-
nant and cause increased expression of IL-4 and IL-13
[17]. In relapse NS,  activated T cell induce IL-4 and
IL-13  secretion,  which  in  turn  triggered  IgE  isotype
switching [17]. 
 Higher IgE group showed increased of IL-4 and
IL-5 expression significantly [25]. [25] further explains
that increased of IL-4 and IL-5 production in idiopathic
NS could  indicate  several  cytokines  involved  in  IgE
production. Allergic treatment with single agent could
not induce NS remission, suggested that increased of
IgE did not cause NS, but reflected allergic response
toward  their  humoral  immunity  perturbation
[10,25,26].
Pan et al.  and [18] consistently agree with Hafez
[4]  about  imbalance  of  Th1/Th2 and  domination  of
Th2 response in NS [4,18,27]. In MCNS, there was an
increased of IL-4, IL-8 and GRO-Ɣ (growth regulated
protein) production.  IL-8 caused altered  permeability
of glomerular basement membrane (GBM) through a
production of HSPGs (Heparan Sulfate Proteoglycans)
which in turn could induce proteinuria in a rat model.
The IL-4 and IL-13 receptor also found in podocytes
and enhanced expression of both receptors  found in
MCNS. Overexpression of IL-13 in the animal model
caused podocyte damage through transduction signal
and  activation  of  the  transcriptional  pathway.
However, the role of IL-4 in podocyte damage still can
not be understood [4]. 
In  this  study,  lower  expression  of  IL-4  in  NS
groups might be caused by administration of glucocor-
ticoid and cytostatic drugs. The subject included in this
study has been a routine visit to pediatric nephrology
policlinic and hospitalized for cytostatic drugs therapy.
Because of this, IL-4 expression mean still did not re-
flect steroid resistant NS, which newly diagnosed. Cy-
tostatic  drugs  that  act  in  T  lymphocyte  and  usually
used  in  NS  is  cyclophosphamide,  chlorambucil  or
cyclosporine. Cyclophosphamide and chlorambucil are
alkylating agents and cross-linked DNA during all cell
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Figure 1. Mean of Plasma 25(OH)D level (ng/mL) in control,
steroid resistant NS, and steroid-sensitive NS group.
* Post Hoc Tukey showed significant differences with
the control group.
Figure  2.  Mean  of  PBMC’s  IL-4  expression  (%)  in  control,
steroid-resistant NS, and steroid-sensitive NS group. 
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cycle phase. Cyclosporine is calcineurin inhibitor that
blocked the production of several cytokines such as IL-
2,  IL-3,  IL-4  and interfered  IL-2 receptor  expression
(CD25) which in turn prevent T cell activation [20].
Other  possible  cause-related  with  the  role  of
Th1/Th2 ratio in the pathogenesis of NS. Glucocorti-
coid  treatment  could  change  Th1/Th2 ratio  through
suppression of proinflammatory cytokines and induced
of anti-inflammatory cytokines as described by Barnes
(2010)  [19].  Barnes  stated  that  GC treatment  could
trans-repressed inflammatory cytokines (IL-2, IL-3, IL-
4,  IL-5,  IL-6,  IL-23,  IL-15,  TNF-α,  GM-CSF,  SCF,
TSLP); chemokines (CCL1, CCL5, CCL11, CXCL8);
inflammatory  enzymes:  iNOS (inducible  nitric  oxide
synthase), COX-2 (inducible cyclo-oxygenase), cPLA2
(inducible  phospholipase  A2);  inflammatory  peptides
(endothelin-1);  mediator receptor:  NK1 (neurokinin),
bradykinin (B2)-receptor; adhesion molecules (iCAM-
1, VCAM-1) and also trans-activated lipocortin-1;  Β2-
Adrenoceptors; Secretory leukocyte inhibitory protein;
IκB-α (inhibitor  NF-κB);  MKP1 (inhibitor  MAP ki-
nase); Glucocorticoid inducible leucine zipper (GILZ);
anti-inflammatory cytokines or inhibitor: IL-10, IL-12,
IL-1 receptor antagonist [19]. 
This  study  also  showed  lower  GR expression  in
steroid-resistant NS group compared with control and
steroid-sensitive NS group. Among three variables, GR
has the highest contribution to steroid resistance in NS
patients.  This  data  are  consistent  with  the  previous
study conducted by [21] which reported that GR den-
sity  in  peripheral  T cell  was  important  factor  deter-
mined GC sensitivity. GR expression could be used as
the  predictor  for  steroid  responsivity  rate  in  adult
MCNS [28].  Wasilewska et  al.  [6]  stated  that  lower
expression  of  GR  caused  a  worse  response  to  GC
treatment. Carlotti et al. [22] showed that GR might be
mediated the occurrence of glucocorticoid resistance in
idiopathic NS. 
Other study showed that autoregulation of GR was
not related with GC response in idiopathic NS patients
[23]. GC sensitivity depends on functionality and ex-
pression  of  its  receptor.  GR expressed  almost  in  all
cells, include convoluted distal tubule cells,  collecting
duct cells, and all part of glomerular cells. GC cellular
response directly correlated with the hormone-binding
capacity [24]. 
This study was designed as observational (cross-sec-
tional) that has a limitation in investigating the causal
effects. Because of that, we suggested to do further re-
search which developed experimentally both in vivo or
in vitro to investigate the role of IL-4, vitamin D, and
GR in NS (especially in newly diagnosed steroid resis-
tant NS patients and focused on Th1/Th2 ratio). Fur-
ther investigation in GR isomer (GRα and GRβ) and
their role in steroid resistance of NS should be per-
formed. Development knowledge in the pathophysiol-
ogy of steroid resistance especially in NS could be fol-
lowed by the development of drugs targeting in mole-
cules that act as the predictor in steroid resistance. 
We conclude that plasma 25(OH)D level, IL-4 and
GR expression was lower in steroid resistant NS group.
GR expression has the highest contribution to steroid
resistance of NS patients. 
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